Physician profile
Hammad Hafeez
NPI 1427044205
$1,236.33
in general payments reported to CMS, 2019-2025
27 companies · $305 in 2025
The $305 reported for 2025 was more than what 84% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $464 · 2020: $209 · 2021: $51.13 · 2022: $39.97 · 2023: $86.37 · 2024: $79.80 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $471.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $215.54 | 2019-2020 | |
| Novo Nordisk INC | $152.69 | 2019-2025 | Rybelsus, Ozempic |
| Novartis Pharmaceuticals Corporation | $94.62 | 2019 | |
| Madrigal Pharmaceuticals | $64.23 | 2025 | Rezdiffra |
| Vifor Pharma, INC. | $63.26 | 2019-2021 | |
| Stryker Corporation | $61.13 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $54.24 | 2024-2025 | Xifaxan |
| Mylan Specialty L.P. | $52.09 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $46.92 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $43.82 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $43.39 | 2019 | |
| Pfizer INC. | $36.34 | 2019-2020 | |
| Advanced Respiratory, INC | $24.90 | 2019 | |
| Paratek Pharmaceuticals, INC. | $24.59 | 2023 | Nuzyra |
| Sk Life Science, INC. | $24.04 | 2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $23.45 | 2023 | Cresemba |
| Exact Sciences Corporation | $23.13 | 2024 | Cologuard Collection Kit |
| Vertex Pharmaceuticals Incorporated | $22.65 | 2025 | |
| Xeris Pharmaceuticals, INC. | $22.29 | 2025 | Gvoke Hypopen |
| Sanofi-Aventis U.S. LLC | $21.37 | 2023 | |
| Dexcom, INC. | $19.60 | 2022 | |
| Alnylam Pharmaceuticals INC. | $18.51 | 2024 | Onpattro |
| Sunovion Pharmaceuticals INC. | $17.90 | 2019 | |
| Abbott Laboratories | $17.62 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Cumberland Pharmaceuticals, INC. | $17.03 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $16.96 | 2023 | Nuedexta |
| Bayer Healthcare Pharmaceuticals INC. | $14.02 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hammad Hafeez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.